ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
ProKidney Corp (Nasdaq: PROK), a late clinical-stage biotech company developing cell therapy for chronic kidney disease (CKD), has announced its participation in two major healthcare conferences this December. The company will join the Evercore HealthCONx Conference on December 3, 2024, featuring a fireside chat at 8:45am ET with a live webcast available. Additionally, ProKidney will participate in the Citi Global Healthcare Conference on December 4, 2024, conducting one-on-one meetings.
The Evercore fireside chat webcast will be accessible through ProKidney's website investor relations section. Interested investors can arrange meetings through their Evercore and Citi representatives.
ProKidney Corp (Nasdaq: PROK), una societ脿 biotecnologica in fase clinica avanzata che sviluppa terapie cellulari per la malattia renale cronica (CKD), ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo dicembre. L'azienda parteciper脿 alla Evercore HealthCONx Conference il 3 dicembre 2024, con un incontro informale previsto per le 8:45 ET, disponibile in diretta streaming. Inoltre, ProKidney parteciper脿 al Citi Global Healthcare Conference il 4 dicembre 2024, conducendo incontri individuali.
Il webcast dell'incontro informale di Evercore sar脿 accessibile attraverso la sezione relazioni con gli investitori del sito web di ProKidney. Gli investitori interessati possono organizzare incontri attraverso i loro rappresentanti di Evercore e Citi.
ProKidney Corp (Nasdaq: PROK), una empresa biotecnol贸gica en etapa cl铆nica avanzada que desarrolla terapia celular para la enfermedad renal cr贸nica (CKD), ha anunciado su participaci贸n en dos importantes conferencias de salud este diciembre. La empresa se unir谩 a la Evercore HealthCONx Conference el 3 de diciembre de 2024, con un chat informal a las 8:45 a.m. ET, disponible en transmisi贸n en vivo. Adem谩s, ProKidney participar谩 en la Citi Global Healthcare Conference el 4 de diciembre de 2024, llevando a cabo reuniones uno a uno.
El webcast del chat informal de Evercore ser谩 accesible a trav茅s de la secci贸n de relaciones con inversores del sitio web de ProKidney. Los inversores interesados pueden organizar reuniones a trav茅s de sus representantes de Evercore y Citi.
ProKidney Corp (Nasdaq: PROK)電� 毵岇劚 鞁犾灔 歆堩櫂(CKD)鞚� 鞙勴暅 靹疙彫 旃橂毳� 臧滊皽頃橂姅 鞛勳儊 頉勱赴鞐� 鞛堧姅 靸濍獏瓿淀暀 須岇偓搿�, 鞚措矆 12鞗旍棎 霊� 臧滌潣 欤检殧 鞚橂 須岇潣鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2024雲� 12鞗� 3鞚检棎 鞐措Μ電� Evercore HealthCONx Conference鞐� 彀胳劃頃橂┌, 鞓れ爠 8鞁� 45攵� ET鞐� 頇旍儊 毂勴寘鞚� 鞓堨爼霅橃柎 鞛堨溂氅�, 霛检澊敫� 氚╈啞霃� 鞝滉车霅╇媹雼�. 霕愴暅 ProKidney電� 2024雲� 12鞗� 4鞚检棎 鞐措Μ電� Citi Global Healthcare Conference鞐愲弰 彀胳棳頃橃棳 鞚茧寑鞚� 須岇潣毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
Evercore鞚� 頇旍儊 毂勴寘 氚╈啞鞚� ProKidney 鞗轨偓鞚错姼鞚� 韴瀽鞛� 甏�瓿� 靹轨厴鞚� 韱淀暣 鞝戧芳頃� 靾� 鞛堨姷雼堧嫟. 甏�鞁� 鞛堧姅 韴瀽鞛愲姅 Evercore 氚� Citi 雽�響滊ゼ 韱淀暣 須岇潣 鞚检爼鞚� 臁办爼頃� 靾� 鞛堨姷雼堧嫟.
ProKidney Corp (Nasdaq: PROK), une entreprise biopharmaceutique en phase clinique avanc茅e d茅veloppant des th茅rapies cellulaires pour la maladie r茅nale chronique (CKD), a annonc茅 sa participation 脿 deux grandes conf茅rences sur la sant茅 en d茅cembre. L'entreprise assistera 脿 la Evercore HealthCONx Conference le 3 d茅cembre 2024, avec un entretien informel pr茅vu 脿 8h45 ET, disponible en direct. De plus, ProKidney participera 脿 la Citi Global Healthcare Conference le 4 d茅cembre 2024, en r茅alisant des r茅unions individuelles.
Le webcast de l'entretien informel d'Evercore sera accessible via la section des relations investisseurs du site Web de ProKidney. Les investisseurs int茅ress茅s peuvent organiser des r茅unions par l'interm茅diaire de leurs repr茅sentants d'Evercore et de Citi.
ProKidney Corp (Nasdaq: PROK), ein biopharmazeutisches Unternehmen in der sp盲ten klinischen Phase, das Zelltherapien f眉r chronische Nierenerkrankungen (CKD) entwickelt, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im Dezember angek眉ndigt. Das Unternehmen wird an der Evercore HealthCONx Conference am 3. Dezember 2024 teilnehmen und ein informelles Gespr盲ch um 8:45 Uhr ET f眉hren, das live gestreamt wird. Dar眉ber hinaus wird ProKidney am Citi Global Healthcare Conference am 4. Dezember 2024 teilnehmen und Einzelgespr盲che f眉hren.
Das Webcast des informellen Gespr盲chs von Evercore wird 眉ber den Bereich Investor Relations auf der Website von ProKidney zug盲nglich sein. Interessierte Investoren k枚nnen Meetings 眉ber ihre Vertreter von Evercore und Citi organisieren.
- None.
- None.
WINSTON-SALEM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK)听(鈥淧roKidney鈥�), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in December:
| Evercore HealthCONx Conference | |
| Date: | December 3, 2024 |
| Time: | 8:45am ET |
| Format: | Fireside Chat |
| Webcast: | |
| 听 | 听 |
| Citi Global Healthcare Conference | |
| Date: | December 4, 2024 |
| Format: | One-on-one meetings |
| 听 | 听 |
The live webcast for the Evercore fireside chat will be accessible through the 鈥淓vents鈥� section of the Investor Relations tab within ProKidney鈥檚 website at . Investors interested in one-on-one meetings should contact their Evercore and/or Citi representatives.
About ProKidney Corp.
ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney鈥檚 lead product candidate, rilparencel (also known as REACT庐), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit .
Investor Contacts:
ProKidney
Ethan Holdaway
[email protected]
LifeSci Advisors, LLC
Daniel Ferry
[email protected]
FAQ
When is ProKidney (PROK) presenting at the Evercore HealthCONx Conference 2024?
What conferences is ProKidney (PROK) attending in December 2024?
How can investors access ProKidney's (PROK) Evercore HealthCONx Conference presentation?
What is the format of ProKidney's (PROK) participation at the Citi Global Healthcare Conference?
